The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury.
Andrea Crespo-CastrilloNatalia Yanguas-CasásMaria Angeles ArevaloIñigo AzcoitiaGeorge E BarretoLuis-Miguel Garcia-SeguraPublished in: Molecular neurobiology (2018)
Previous studies have shown that estradiol reduces reactive gliosis after a stab wound injury in the cerebral cortex. Since the therapeutic use of estradiol is limited by its peripheral hormonal effects, it is of interest to determine whether synthetic estrogenic compounds with tissue-specific actions regulate reactive gliosis. Tibolone is a synthetic steroid that is widely used for the treatment of climacteric symptoms and/or the prevention of osteoporosis. In this study, we have assessed the effect of tibolone on reactive gliosis in the cerebral cortex after a stab wound brain injury in ovariectomized adult female mice. By 7 days after brain injury, tibolone reduced the number of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes, the number of ionized calcium binding adaptor molecule 1 (Iba1) immunoreactive microglia, and the number of microglial cells with a reactive phenotype in comparison to vehicle-injected animals. These effects on gliosis were associated with a reduction in neuronal loss in the proximity to the wound, suggesting that tibolone exerts beneficial homeostatic actions in the cerebral cortex after an acute brain injury.
Keyphrases
- brain injury
- subarachnoid hemorrhage
- cerebral ischemia
- functional connectivity
- neuropathic pain
- inflammatory response
- surgical site infection
- induced apoptosis
- wound healing
- postmenopausal women
- estrogen receptor
- liver failure
- ionic liquid
- extracorporeal membrane oxygenation
- drug induced
- respiratory failure
- oxidative stress
- cell proliferation
- binding protein
- combination therapy
- intensive care unit
- acute respiratory distress syndrome
- adipose tissue
- type diabetes
- hepatitis b virus
- dna binding
- insulin resistance
- sleep quality
- childhood cancer